Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma

Contributions: all named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published